Sunshine Biopharma, Inc. SBFM
2.85 USD +0.10 (+3.64%)
At closeNov 10, 2026, 5:49 PM EST
2.80 -0.05 -1.75%
After hours · Nov 10, 5:49 PM ET
2.68 Day range 2.85
2.53 52-week range 464.00
- YTD
- -98.84%
- 1 year
- -99.17%
News
accessnewswire.com Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing FORT LAUDERDALE, FL / ACCESS Newswire / October 22, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company specializing in generic and specialty prescription…
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 30.4% to $10.58 during Thursday's regular session. The company's market cap stands at $4.0 billion. SenesTech (NASDAQ:SNES) stock rose…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Alaunos Therapeutics (NASDAQ:TCRT) stock moved upwards by 203.8% to $3.19 during Tuesday's regular session. The company's market cap stands at $2.6 million. Picard Medical (AMEX:PMI) stock…
defenseworld.net Sunshine Biopharma, Inc. (NASDAQ:SBFM) Sees Significant Growth in Short Interest Sunshine Biopharma, Inc. (NASDAQ: SBFM - Get Free Report) saw a significant increase in short interest during the month of September. As of September 30th, there was short interest totaling 131,478…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Quantum-Si (NASDAQ:QSI) stock rose 30.3% to $1.59 during Friday's regular session. The company's market cap stands at $267.0 million. Nautilus Biotechnology (NASDAQ:NAUT) stock rose 26.09% to…
accessnewswire.com Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering $6.0 million upfront with an additional $14.4 million of potential aggregate gross proceeds upon the exercise of warrants FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2026 / Sunshine Biopharma…- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Pacira BioSciences (NASDAQ:PCRX) shares moved upwards by 44.0% to $36.3 during Thursday's regular session. The company's market cap stands at $1.0 billion. Onconetix (NASDAQ:ONCO) stock rose…
benzinga.com Crude Oil Gains 5%; PepsiCo Posts Upbeat Q3 Earnings U.S. stocks fell Thursday as Nasdaq slid 150+ points; energy rallied, healthcare dropped. PepsiCo beat estimates but cut FY26 outlook; oil jumped 5%.
benzinga.com Dow Falls Over 100 Points; US Initial Jobless Claims Decline U.S. stocks fell Thursday, led by tech, while energy rose and oil jumped 4.8%. Jobless claims eased to 197,000; small caps posted sharp swings.- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Profound Medical (NASDAQ:PROF) shares moved upwards by 21.5% to $6.9 during Thursday's pre-market session. The company's market cap stands at $207.5 million. Haemonetics (NYSE:HAE) stock…
accessnewswire.com Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering FORT LAUDERDALE, FL / ACCESS Newswire / October 8, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company specializing in generic and specialty prescription…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 186.0% to $3.58 during Wednesday's regular session. Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 151.31% to $1.0. The…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 64.0% to $2.05 during Tuesday's after-market session. The market value of their outstanding shares is at $1.1 million. Neogen…
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers HeartBeam (NASDAQ:BEAT) stock moved upwards by 70.5% to $0.74 during Monday's regular session. The market value of their outstanding shares is at $24.4 million. PDS Biotechnology…
benzinga.com US Stocks Mixed; Nasdaq Gains Over 50 Points U.S. stocks mixed: Nasdaq and S&P 500 rose while Dow dipped. Weak jobs data pressured outlook; oil fell, while gold, silver and copper gained.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Apimeds Pharmaceuticals (AMEX:APUS) stock moved upwards by 76.7% to $5.69 during Monday's pre-market session. The market value of their outstanding shares is at $4.8 million. Alector…
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-market session. The market value of their outstanding shares is at $34.9 million. Intelligent Bio Solutions…
benzinga.com Sunshine Biopharma Amends Articles Of Incorporation To Allow For Reverse Stock Split Of Up To 1-For-20; Board Of Directors Has Discretion To Effect The Split On September 15, 2026, the Company received written consent in lieu of a meeting of stockholders from Dr. Steve N. Slilaty, our Chief Executive Officer, the holder of approximately 97% of the total…
zacks.com Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know Sunshine Biopharma, Inc. (SBFM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
benzinga.com Sunshine Biopharma Launches Generic Ondansetron Tablets Of 4mg And 8mg In Canadian Market Launch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with chemotherapy, radiation therapy and surgeryGlobal ondansetron market projected to reach $2.98 billion by…
accessnewswire.com Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio Launch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with chemotherapy, radiation therapy and surgery Global ondansetron market projected to reach $2.98 billion by…
benzinga.com Sunshine Biopharma Says CEO Steve Slilaty, Holder Of About 97% Of Voting Power, Approved Reverse Stock Split Of Up To 1-For-20 By Written Consent https://www.sec.gov/ix?doc=/Archives/edgar/data/0001402328/000168316826007193/sunshine_8k.htmhttps://www.sec.gov/Archives/edgar/data/1402328/000168316826007195/sunshine_pre14c.htm
accessnewswire.com Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies Nanomolar potency against PLpro with broad-spectrum SARS-CoV-2 variants activity Significant dose-dependent suppression of pulmonary viral replication in vivo Strong oral bioavailability and…
benzinga.com EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies Sunshine Biopharma advances its lead coronavirus drug candidate into IND-enabling studies after strong preclinical results in animal models.
benzinga.com Sunshine Biopharma Announces Approval Of Atenolol Tablets Of 25mg, 50mg And 100mg For Canadian Market Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its…
accessnewswire.com Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions FORT LAUDERDALE, FL / ACCESS Newswire / August 31, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…
benzinga.com Sunshine Biopharma Announces Updates On Its K1.1 mRNA Tumor Suppressor; Outlines Plans For Program Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company offering and researching life-saving medicines across multiple therapeutic areas including oncology and…
accessnewswire.com Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer K1.1 mRNA demonstrated tumor-suppressing activity as a single agent in multiple in vivo hepatocellular carcinoma models Program targets a tumor suppressor frequently mutated in difficult-to-treat…
benzinga.com EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer Sunshine Biopharma outlines K1.1 mRNA pipeline updates, advancing dual oncology therapy to target cold tumors in liver and lung cancer.- benzinga.com Sunshine Biopharma Announces Approval Of Generic Enalapril Tablets 2.5mg, 5mg, 10mg And 20mg For Canadian Market Global anti-hypertensive drug market projected to reach $37.24 billion by 2034Enalapril is a widely prescribed ACE inhibitor used to treat hypertension, heart failure and left ventricular…
accessnewswire.com Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market Global anti-hypertensive drug market projected to reach $37.24 billion by 2034 Enalapril is a widely prescribed ACE inhibitor used to treat hypertension, heart failure and left ventricular…
benzinga.com EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug Sunshine Biopharma secures Canadian regulatory approval for generic Enalapril tablets to treat high blood pressure by 2026.
accessnewswire.com Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market Sunshine Biopharma's Amoxicillin now shipping to Canadian pharmacies in multiple dosages and strengths Launch expands Sunshine Biopharma's growing portfolio of essential prescription medications…
accessnewswire.com Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval Dienogest is first-line therapy for pelvic pain associate with endometriosis The endometriosis treatment market is projected to reach $5.2 billion by 2034 FORT LAUDERDALE, FL / ACCESS Newswire /…
benzinga.com EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval Pharmaceutical firm Sunshine Biopharma Inc. (NASDAQ:SBFM) on Tuesday said it received regulatory approval to introduce its 2mg generic Dienogest tablets to the Canadian market.
benzinga.com EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval Sunshine Biopharma secures Canadian approval for its generic 2mg Dienogest tablets, expanding into women's health.
defenseworld.net Reviewing Foghorn Therapeutics (NASDAQ:FHTX) and Sunshine Biopharma (NASDAQ:SBFM) Sunshine Biopharma (NASDAQ: SBFM - Get Free Report) and Foghorn Therapeutics (NASDAQ: FHTX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare…
accessnewswire.com Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting FORT LAUDERDALE, FL / ACCESS Newswire / July 28, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 25.1% to $3.79 during Monday's after-market session. The company's market cap stands at $1.8 million. China Pharma Holding…
accessnewswire.com Sunshine Biopharma and University of Arizona Publish Significant New Research Findings FORT LAUDERDALE, FL / ACCESS Newswire / July 20, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…
defenseworld.net Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Down 35.0% in June Sunshine Biopharma, Inc. (NASDAQ: SBFM - Get Free Report) saw a significant drop in short interest in the month of June. As of June 30th, there was short interest totaling 113,463 shares, a drop of…- benzinga.com Sunshine Biopharma Announces Approval Of Generic Anastrozole Tablets Of 1mg For Canadian Market Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its…
accessnewswire.com Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R) FORT LAUDERDALE, FL / ACCESS Newswire / June 25, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…
benzinga.com Why Hewlett Packard Enterprise Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket HPE stock jumps 26.55% after reporting strong revenue growth. Top gainers are DXST, MRVL and more. Top losers are FULC, JZ, and more.- benzinga.com Sunshine Biopharma Receives Canada Approval For Its Generic Rivaroxaban Tablets Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its…
accessnewswire.com Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R) FORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…
accessnewswire.com Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology FORT LAUDERDALE, FL / ACCESS Newswire / May 29, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription…
benzinga.com Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today Sunshine Biopharma stock fell after hours after the company announced a 1-for-10 reverse stock split to maintain Nasdaq listing compliance.
benzinga.com Dow Jumps Around 200 Points; Best Buy Posts Upbeat Q1 Results U.S. stocks rise, Dow Jones gains 200 points. NASDAQ up 0.73%, S&P 500 up 0.56%. Health care shares jump 1.4%, financial stocks fall 0.5%. Best Buy beats expectations. 3 E Network Technology Group…- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session